1,078 results on '"Heneghan, Michael A."'
Search Results
202. FRI-371 - The role of Type II and III Interferons in primary biliary cholangitis
203. OS-053-YI - Type of calcineurin inhibitor versus long-term outcome following liver transplantation for primary biliary cholangitis-an ELTR study
204. OS-037 - Pregnancy outcomes in women with liver cirrhosis: a prospective UK obstetric surveillance system national cohort study
205. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese
206. Fulminant Hepatic Failure
207. Repurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
208. The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
209. Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study
210. Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand
211. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis
212. Autoimmune Hepatitis and Pregnancy
213. Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre
214. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis
215. Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome
216. Response letter to ‘role of thiopurine metabolite measurement in the management of autoimmune hepatitis’
217. Gender and Age at Diagnosis as Factors for Ursodeoxycholic Acid (UDCA) Response in Primary Biliary Cirrhosis (PBC) in the UK-PBC Patient Cohort: a Role for Estrogen as a Disease Co-Factor?: 2028
218. Gender Differences in Symptom Impact in Primary Biliary Cirrhosis (PBC): Evidence From the UK-PBC Patient Cohort for a Direct Role for Autonomic Dysfunction in Fatigue: 2020
219. Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary biliary cirrhosis risk: 2021
220. Hepatitis C virus infection abrogates the effect of liver transplantation on NK cell activation: 1967
221. Outcome of Patient Declined for Liver Transplantation; Should Prognostic Scores Guide Proactive Palliative Care Review?: 1936
222. Long-Term Outcome In Severe Alcoholic Hepatitis: 1704
223. Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in budd-chiari syndrome and their impact on thrombotic complications post Liver Transplantation
224. Liver Transplantation in Human Immunodeficiency Virus–Infected Patients: Procoagulant, but Is Antithrombotic Prophylaxis Required?
225. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
226. LIVER TRANSPLANTATION FROM CARDIAC DEATH DONATION: CURRENT EXPERIENCE IN A SINGLE CENTRE: O-290
227. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence
228. Early Predictors of Corticosteroid Treatment Failure in Icteric Presentations of Autoimmune Hepatitis Δ
229. A unique type of fully covered metal stent for the management of post liver transplant biliary anastomotic strictures
230. O9 Redefining poor prognostic criteria for acetaminophen-induced acute liver failure using regeneration and cell-death linked miRNA signatures
231. P30 Is a virtual pharmacy-led hub and spoke model effective in managing primary biliary cholangitis with obeticholic acid?
232. Review article: experimental therapies in autoimmune hepatitis
233. Inequality in access to liver transplant: are satellite liver transplant centres the answer?
234. Patients with autoimmune hepatitis and liver cirrhosis have disease activity despite normal transaminases
235. Early diagnosis of alcohol-related liver disease and timely intervention: the role of alcohol care teams
236. Patient social and lifestyle factors associated with cardiovascular risk affect decisions regarding transplant candidacy more than factors associated with psychological and financial well-being
237. Validating the Swansea criteria in a single-centre study with cohorts of patients with acute fatty liver of pregnancy and haemolysis, elevated liver enzymes and low platelets syndrome: is it time to modify the criteria?
238. Utility of thiopurine metabolite testing in autoimmune hepatitis: defining an optimal therapeutic range for disease management and measurement may avert relapse and adverse drug reactions
239. Pregnancy outcomes for women with primary sclerosis cholangitis and primary binary cholangitis
240. The association between liver fibrosis and cognitive impairment in type 2 diabetes: a cross-sectional sub-study of the south London diabetes cohort
241. High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
242. De novo perihilar cholangiocarcinoma arising in the allograft liver 15 years post‐transplantation for biliary atresia
243. Reply
244. Pregnancy in Liver Transplantation
245. A unique type of fully covered metal stent for the management of post liver transplant anastomotic strictures
246. Managing Pregnant Women with Autoimmune Liver Disease
247. Normal neurological outcome in two infants treated with exchange transfusions born to mothers with Crigler-Najjar Type 1 disorder
248. Neutrophil gelatinase—Associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation
249. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs
250. Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.